Found 8 matching trials
ICRA Randomised Controlled Trial
PHASE3The standard of care for advanced stage epithelial ovarian cancer is primar...
Location
University College London Hospitals NHS Foundation Trust
Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
PHASE2About 70% of epithelial ovarian cancer patients are diagnosed at advanced s...
Location
The University of Hong Kong
Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
PHASE2This trial proposes to evaluate the immunologic and potential clinical effe...
Location
UMPC Hillman Cancer Center
Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis
PHASE3Patients with histological proven gastric cancer (including cancer of the e...
Location
Klinik für Allgemein-, Visceral-, Gefäß- und ThoraxchirurgieCharité Campus Mitte
ERAS® Guidelines Validation of CRS With or Without HIPEC
N/AEnhanced recovery after surgery (ERAS®) pathways have been shown to conside...
Location
University of Texas Southwestern Medical Center
Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
NAOvarian cancer is among the top five primary causes of cancer-related morta...
Location
Elshatby Maternity University Hospital
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial
NABACKGROUND: For synchronous metastatic renal cell carcinoma (RCC), surgical...
Location
Department of Oncology, Aarhus University Hospital
Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer
N/ATo compare patient outcomes following interval and delayed cytoreductive su...
Location
The Royal London Hospital